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Stem extracts of Commelina benghalensis (Linn.), although not extensively documented, are frequently 
used in traditional medicine for the treatment of ailments such as skin malformations and outgrowths. 
Accordingly, the study was aimed to investigate possible molecular mechanisms that are associated 
with the potential anti-carcinogenic property of this agrofield weed. Jurkat T cells were exposed to 
different concentrations (0-600 µg/ml) of the crude methanolic extract of C. benghalensis to evaluate 
their growth inhibitory and apoptosis inducing effects. The extract elicited a dose- and time-dependent 
inhibition of cell proliferation, followed by a concomitant decrease in cell viability. The observed 
cytotoxicity was linked to the induction of apoptosis as determined by morphological and biochemical 
features known to be associated with the advent of apoptosis. Real time quantitative RT-PCR and 
Western blot analyses of Bax, Bcl-2 and p53 exhibited aberrant expression profiles of these genes 
under various treatment conditions. Taken together, the data suggest that the crude methanolic extract 
of C. benghalensis contains bioactive compounds that may be beneficial in the treatment of malignant 
growths, and that this apparent antineoplastic activity is a consequence of dysregulated expression of 
apoptosis-responsive genes. These observations could provide a credible scientific justification upon 
which the ethnopharmacological utilisation of C. benghalensis is founded. 
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INTRODUCTION 
 
Plant-derived compounds and extracts have traditionally 
played important roles in the treatment of a number of 
human diseases (Farnsworth, 1984; Cox, 1994; 
Taraphdar et al., 2001). Recent studies suggest that a 
number of anticancer drugs have side effects and 
encounter resistance from slow growing cancers. Thus, 
there is a need to develop new, safe and effective 
prototype anticancer drugs from  natural  products  (Yang  
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et al., 2000; Taylor et al., 2001). Indeed, recent studies 
on tumour inhibitory compounds of plant origin have 
yielded an impressive array of novel structures, with 
notable drugs such as taxol. These new prototypes could 
serve as templates in the design of potential chemo-
therapeutic agents. A successful anticancer drug should 
kill or incapacitate cancer cells without causing excessive 
damage to normal cells (Yi et al., 2003). This ideal 
situation is achievable by inducing apoptosis in cancer 
cells. 
Apoptosis is a defined form of cell death, which plays 
an important role in the development of multicellular 
organisms and in the regulation and  maintenance  of  the  
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populations in tissues under physiological and patholo-
gical conditions (Leist and Jaattela, 2001). Apoptotic cells 
are characterised by a number of morphological features 
such as cell shrinkage, membrane blebbing, chromatin 
condensation and the formation of apoptotic bodies 
(Zimmerman et al., 2001; Orienius, 2004). Some of the 
morphological changes associated with apoptosis occur 
as a result of the activation of endogenous endonu-
cleolytic and proteolytic (caspases) enzymes that, in turn, 
mediate the cleavage of DNA into fragments as well as 
protein substrates, which usually determine the integrity 
and shape of the cytoplasm and organelles (Seraste and 
Pulkki, 2000; Denault and Salvesen, 2002; Kasibhatla 
and Tseng, 2003). Furthermore, apoptosis is regulated 
and executed by different interplay of many genes res-
ponsive to various stimuli (Huang and Cidlowski, 2002). 
The most widely studied genes involved in apoptosis are 
the bcl-2 family members and p53; these are major 
regulators of the apoptotic process, whereas caspases 
are the major executioners (Cohen, 1997). 
The tumour suppressor protein p53 is a transcription 
factor that regulates various genes involved in the 
regulation of cellular response to DNA-damage, cell cycle 
control and induction of apoptosis (Xie and Shaikh, 2006; 
Liu et al., 2007). p53 is reported to induce apoptotic cell 
death by directly or indirectly modulating the expression 
of the Bcl-2 family of proteins (Bax and Bcl-2). The Bcl-2 
family of proteins play an important role in the control of 
apoptosis by regulating mitochondrial membrane 
permeability (Hofseth et al., 2004). The family includes a 
number of anti-apoptotic members such as Bcl-2 and Bcl-
XL, as well as pro-apoptotic members including Bax and 
Bad (Scatena et al., 1998). Bax is a pro-apoptotic mem-
ber of the Bcl-2 family that resides in the cytosol. 
Together with other pro-apoptotic family members, Bax 
promotes apoptosis by forming homodimeric and hetero-
dimeric complexes that result in the formation of channels 
or pores on the mitochondrial membrane to facilitate the 
release of cytochrome c and apoptosis-inducing factors 
(AIFs) from mitochondrial intermembrane spaces into the 
cytosol. The formation of these pores results in the loss 
of the selective ion permeability across the mitochondrial 
membrane. The intracisternal contents that are released 
into the cytosol triggers a cascade of events that 
culminate in the execution of apoptosis through activation 
of caspases (Israels and Israels, 1999). 
In contrast, the anti-apoptotic Bcl-2 protein localises the 
outer mitochondrial membrane and mediates its anti-
apoptotic effects by stabilising the integrity of the 
mitochondrial membrane. The stabilisation of the 
mitochondrial membrane leads to the inhibition of the 
permeability transition pore and the release of cyto-
chrome c (Vander and Thompson, 1999), and this is 
achieved by formation of heterodimers with pro-apoptotic 
members of such as Bax and Bak, thus neutralising their 
activity (Zörnig et al.,  2001).  Indeed,  heterodimerisation  
 
 
 
 
of pro- and anti-apoptotic proteins was shown to antago-
nise apoptosis (Zörnig et al., 2001). Thus, the sensitivity 
of cells to apoptotic stimuli will depend upon the relative 
ratios of Bax/Bax homodimers, Bax/Bcl-2 heterodimers 
and Bcl-2/Bcl-2 homodimers (Israels and Israels, 1999). 
Additionally, over expression of Bcl-2 prevents the 
activation of caspases in apoptosis and hypoxia-induced 
necrosis, suggesting that Bcl-2 prevents cell death by 
acting upstream of the activation of caspases 
(Chinnaiyan and Dixit, 1996). 
Commelina benghalensis Linn. [family: Commelina-
ceae] commonly known as the Benghal dayflower or 
tropical spiderwort, is an annual or perennial herb native 
to the tropical and subtropical Asia and Africa. It is widely 
distributed in the eastern and northern parts of South 
Africa, including the Limpopo province. The stem sap 
squeezed from C. benghalensis is topically used, in local 
traditional medicine, for the treatment of skin lumps or 
skin outgrowths (K. Mabela, personal communication). In 
the Chhattisgarh province of India, C. benghalensis 
(locally called common Rice weed or Kaua-Kaini) is used 
by senior traditional healers in the treatment of cancer 
(http://botanical.com/site/column_poudhia/articles/_11840
.html). Additionally, the plant is used medicinally in China 
as a diuretic, febrifuge and an anti-inflammatory agent 
(Hong and DeFillipps, 2000). The plant is also used as 
animal fodder and vegetable, as a laxative and to cure 
inflammations of the skin as well as leprosy (Qaiser and 
Jafri, 1975). However, there is virtually no scientific 
substantiation to support and validate the above claims. It 
was, therefore, the objective of this study to try to 
delineate and validate some of the cellular and molecular 
mechanism(s) associated with the anticancer activity of 
C. benghalensis L. 
 
 
MATERIALS AND METHODS 
 
Reagents 
 
RPMI-1640 media and foetal bovine serum (FBS) were purchased 
from Highveld Biologicals (Pty) Ltd, Lyndhurst, South Africa. 
Penicillin, streptomycin and neomycin, (PSN) antibiotic cocktail from 
Gibco, Auckland, New Zealand. Monoclonal IgG primary antibodies, 
Goat anti-mouse IgG-HRP conjugated secondary antibodies, and 
Western blotting luminol reagent from Santa-Cruz, Biotechnology Inc., 
USA. DMSO and Tween-20 from Merck Laboratory Suppliers (Pty). 
Sodium dodecyl-sulphate (SDS), BDH Laboratory Suppliers. 
Phenylmethylsulfonyl fluoride (PMSF) from Boehringer-Mannheim, 
Germany. Bromophenol blue, Coomassie blue R200, Sodium 
chloride, Ethanol, and Methanol from Saarchem (Pty) Ltd, South 
Africa. 
 
 
Preparation of crude extract 
 
Frozen stems of C. benghalensis (CB) were minced in liquid 
nitrogen using a wharing blendor. Ground stems were weighed and 
exhaustively extracted with absolute methanol (1 g/10 ml, w/v) at 
room temperature for 24 h.  The  resultant  methanolic  extract  was  
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Table 1. The primers used for the amplification of the respective genes in the 
real time quantitative RT-PCR. 
 
Gene Primer Sequence 
Bax Forward primer: 5'-GCCCTTTTGCTTCAGGGTTT-3' 
Reverse primer: 5'-TCC AAT GTC CAG CCC ATG AT-3' 
Bcl-2 
Forward primer: 5'-GACAGAAGATCATGCCGTCC-3' 
Reverse primer: 5'-GGTACCAATGGCACTTCAAG-3' 
GAPDH Forward primer: 5'- ACCCACTCCTCCACCTTTG-3' Reverse primer: 5'- CTCTTGTGCTCTTGCTGGG-3' 
HPRT Forward primer: 5'-TGACACTGGCAAAACAATGCA-3' Reverse primer: 5'-GGTCCTTTTCACCAGCAAGCT-3' 
 
 
 
then filtered through No.2 Whatman filter paper and the filtrate was 
dried at 40oC under low pressure using a Büchi rotavapor R-205 
(Büchi Labortechnik AG, Switzerland). The dried extract was 
weighed and dissolved in 100% dimethyl sulphoxide (DMSO) to an 
appropriate concentration and stored as a stock solution under dark 
conditions at -20oC until required. 
 
 
Cell culture and treatment 
 
Jurkat T cells were obtained from the American type culture collec-
tion (ATCC, Baltimore, USA). The cultures were grown and 
maintained in tissue culture flasks at 37°C in a humidified atmos-
phere at 95% air/5% CO2 in RPMI-1640 supplemented with 10% 
(v/v) heat inactivated foetal bovine serum (FBS) and 1% antibiotic 
(Penicillin, Streptomycin and Neomycin, PSN) cocktail. For the 
treatment of experimental cultures, the extract solution (stock) was 
diluted with RPMI-1640 medium supplemented with 10% FBS to 
give final concentrations ranging from 0 to 600 µg/ml. The prepared 
concentrations were filter sterilised through a 0.22 µm pre-sterilised 
GP express plus steritop™ filter (Millipore Corporation, MA, USA) 
before testing. Both solvent controls (DMSO) and experimental 
cultures received equivalent amounts of DMSO at concentrations 
less than 0.1%. Normal Monkey Vero cells were used as normal 
control cells. 
 
 
Cell proliferation and assessment of cell viability 
 
To determine the effect of the crude methanolic extract of C. 
benghalensis (CMECB) in respect of dosage and time on cell 
growth, Jurkat T cells (1x105 cells/ml) were treated with different 
concentrations (0, 100, 250, 400 and 600 µg/ml) of the extract and 
incubated for 24, 48 and 72 h. To assess the effect of the extract on 
cell proliferation after each treatment, cells were sampled and 
counted at different times of incubation using a Coulter counter 
model Z1 (Coulter Electronics, (Pty), Ltd, UK). Cell viability was 
assessed by staining cells with 0.4% trypan blue dye. Numbers of 
dead and viable cells were counted using a haemocytometer under 
a light microscope (Carl Zeiss, Germany); cell viability was 
expressed as percentage per 100 cells counted.  
 
 
Morphological examination of apoptosis 
 
The morphology of experimental cultures was analysed by fluore-
scence microscopy after 24 h of treatment. CMECB-treated and 
untreated cells were harvested by centrifugation (100 x g), washed 
twice in ice-cold phosphate-buffered saline, PBS (pH 7.4), and re-
suspended in 300 µg/ml acridine orange/1 mg/ml ethidium bromide 
dual stain in PBS (pH 7.4) for 10 min. Cellular and nuclear 
morphological changes indicative of the occurrence of apoptosis 
were then evaluated under fluorescence microscopy (Axioplan, 
Zeiss, Germany). Acridine orange stains early stage apoptotic cells, 
whereas late-stage apoptotic cells (that have lost their membrane 
integrity) stain with ethidium bromide. 
 
 
Real time quantitative RT-PCR analysis of apoptosis-regulatory 
genes  
 
Expression levels of Bax and Bcl-2 mRNA were analysed by the 
real time quantitative reverse transcription-polymerase chain reac-
tion (qRT-PCR) technique. Experimental cells were treated with 
various concentrations of CMECB and then harvested at 24, 48 and 
72 h. The cells were washed twice with ice-cold PBS. Total RNA 
was isolated using the high pure RNA isolation kit according to the 
manufacturer′s instructions (Perkin-Elmer, Roche Diagnostics). The 
integrity and purity of RNA was electrophoretically verified by 
formaldehyde agarose gel stained with ethidium bromide and 
optical density (OD) absorption ratio OD260nm/OD280nm, respectively. 
One microgram (1 µg) of RNA was reverse transcribed into cDNA 
in a reverse transcription reaction mixture containing 1x PCR buffer, 
0.5 mM deoxy-nucleoside triphosphates (dNTPs), one unit of 
RNase inhibitor, 2.5 µM of oligo d(T)16, and 2.5 units of MuLV 
reverse transcriptase (Perkin-Elmer, Roche Molecular Systems, Inc, 
New Jersey, USA). After 10 min of incubation at room temperature 
to allow primer annealing, the reaction mixture was incubated at 
42oC for 15 min, heated to 95oC for 5 min, and chilled at 4oC for 5 
min in a GeneAmp thermal cycler (Applied Biosystems). Two 
microliters (2 µl) of the resultant cDNA products was used for PCR 
amplification. 
Real time quantitative RT-PCR was performed on a Lightcycler 
2.0 system (Roche Applied Systems) to analyse the expression 
levels of Bax and Bcl-2 relative to the housekeeping genes, HPRT 
and GAPDH. Primers sets for HPRT, GAPDH, Bax and Bcl-2, were 
designed using the Real-Time Quantitative PCR probe design 
software (Roche Applied Systems). The primers used for the 
amplification of the respective genes are listed in Table 1. PCR 
reactions for these primers were first optimised using conventional 
PCR and product sizes were verified by electrophoresis on a 2% 
agarose gel. 
For quantitative Real-Time PCR, 20 µl amplification mixtures 
(LightCycler Faststart DNA MasterPLUS SYBR Green  Reaction  Mix;  
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Figure 1. The effects of CMECB on the proliferation (A) and viability 
(B) of Jurkat T cells. Cells were cultured with or without different 
concentrations of CMECB for 24, 48 and 72 h. Cell number and 
percentage cell viability were determined using a Coulter counter 
and trypan blue dye exclusion assay, respectively. Each data point 
represents the mean ± S.D value of three independent experiments 
performed in triplicates. *Indicates the statistical difference between 
control and CMECB treated cells. *p<0.05, **p<0.01. 
 
 
 
Roche Applied Science) were prepared as per manufacturer’s 
instructions, containing cDNA (equivalent to 100 ng reverse-
transcribed RNA) and 0.5 µM of each primer (Table 1). The cycling 
conditions were: 10 min polymerase activation at 95oC and 40 
cycles at 95oC for 15 s, 58oC for 15 s, and 72oC for 15 s. 
Quantification of the molecular concentration of template cDNA 
was performed with the standard curve method for relative 
quantification. The Real-Time PCR efficiencies (E) were calculated 
for each gene. The baseline and the threshold were automatically 
set by the software. The crossing point of the amplification curve 
with the threshold represents the cycle threshold (Ct). In addition, 
the real-time reaction of the products was checked by melting point 
analysis after each reaction.  
The expression levels of Bax and Bcl-2 was determined relative 
to HPRT and GAPDH using both the geNORM excel spreadsheet 
(Vandesompele et al., 2002) and the Relative expression software 
tool (REST-384) (Pfaffl et al., 2002). 
 
 
Western blotting 
 
After treatment with various concentrations of CMECB, cells were 
collected by centrifuging at 100 x g and washed twice  with  ice-cold  
 
 
 
 
PBS (pH 7.4) and lysed in 1 ml lysis buffer (2 mM Tris-HCl, pH 8.0, 
1% Nonident P-40, 13.7 mM NaCl, 10% glycerol, 1 mM sodium 
orthovanadate (NaVO3), 1 mM phenylmethyl-sulfonyl fluoride and 
10 µg/ml Aprotinin) for 20 min on ice. Lysates were centrifuged at19 
000 x g for 15 min at 4°C, and aliquots of the supernatants were 
used to determine protein concentration using the BCA assay 
(Pierce, Rockford, USA). Aliquots containing equal amounts of 
proteins (20 - 30 µg) were boiled in 2 x sodium dodecyl sulfate 
(SDS) sample loading buffer (125 mM Tris-HCl, 4% (w/v) SDS, 20% 
(v/v) glycerol, 10% (v/v) 2-mercaptoethanol, pH 6.8) before being 
resolved on a 12% sodium dodecyl sulfate-polyacrylamide gel 
(SDS-PAGE). Proteins on the gels were then electro-blotted onto 
Immobilon-P transfer membrane (Millipore Corporation, Bedford, 
USA) using a blotting buffer (10% methanol, 10 mM CAPS, pH 
11.0) at 200 mA for 2 h at 4°C. Following electro-blotting, the 
membranes were blocked with 0.05% TBS-Tween (20 mM Tris-HCl, 
200 mM NaCl, pH 7.4) containing 5% non-fat dry milk for 1 h at 
room temperature. After blocking, the membranes were washed 
three times for 10 min each with wash buffer (0.05% TBS-Tween 
without milk), and then incubated with specific primary goat anti-
mouse Bcl-2 antibody (1: 1000), goat anti-mouse Bax antibody (1: 
500), and goat anti-mouse p53 antibody (1: 1000) for overnight at 
4°C. After washing three times with washing buffer for 10 min each, 
membranes were further incubated for 1 h in the presence of a 
peroxidase (HRP)-conjugated secondary antibody (1: 10 000) 
diluted with blocking buffer. The membranes were washed again as 
described above and immunoreactive proteins were then detected 
using the Western blotting luminol reagent (Santa-Cruz Biotechno-
logy Inc., Santa-Cruz, CA, USA) following the manufacturer’s 
protocol.  
 
 
Statistical analysis 
 
The results of each series of experiments (performed in triplicates) 
are expressed as the mean values ± standard deviation of the 
mean (SD). Levels of the statistical significance were calculated 
using the paired student t-test when comparing two groups, or by 
analysis of variance (ANOVA). P-values of ≤ 0.05 were considered 
significant. 
 
 
RESULTS 
 
CMECB inhibits cancer cell growth 
 
To evaluate the potential use of CMECB as a chemothe-
rapeutic agent, Jurkat T cells were incubated in the 
absence or presence of different concentrations of the 
extract for 24, 48 and 72 h. CMECB was demonstrated to 
inhibit cellular proliferation of Jurkat T cells in a dose- and 
time-dependent manner (Figure 1A). This anti-prolife-
rative property of CMECB suggested cell death in the 
experimental cultures. This was confirmed by cell viability 
assay using the trypan blue dye exclusion method. The 
results demonstrated that CMECB not only inhibited 
cellular proliferation of Jurkat T cells but also decreased 
their viability in a dose- and time-dependent manner 
(Figure 1B). Statistically significant (p-value ≤0.05) inhibi-
tion of cell proliferation and reduction in cell viability was 
observed at high doses of the extract. Normal Monkey 
Vero  cells  were  used  as  normal  control  cells.  Extract  
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Figure 2. Cellular and nuclear morphological changes of Jurkat T 
cells following exposure to various concentrations of CMECB for 24 
h. Experimental conditions were as follows: A = untreated cells in 
the presence of DMSO, B = 100 µg/ml, C = 250 µg/ml, D = 400 
µg/ml and E = 600 µg/ml. Note the morphological features that are 
indicative of cells undergoing apoptosis (see arrows). 
 
 
 
concentrations of up to 500 µg/ml were demonstrated to 
be non-cytotoxic to normal Monkey Vero cells tested 
(data not shown). 
 
 
CMECB induces morphologic changes indicative of 
apoptosis 
 
Cellular and nuclear morphological changes of CMECB-
treated cells were assessed to determine whether the 
observed anti-proliferative effects, and the concomitant 
decrease in cell viability, were a consequence of an 
apoptotic process. Extract-treated cells displayed mor-
phological changes typical of an apoptotic process 
including cellular shrinkage, condensation and margina-
tion of the chromatin, and the formation of apoptotic 
bodies (Figure 2B-2E). On the other hand, untreated cells 
showed intact chromatin and the normal round-to-oval 
cellular shapes (Figure 2A). These results suggest that 
CMECB induces Jurkat T cell death through the process 
of apoptosis. 
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CMECB modulates Bax-to-Bcl-2 mRNA expression 
ratio  
 
The Bcl-2 family of proteins plays an important role in the 
regulation of apoptosis. Thus, in order to understand the 
molecular or biochemical mechanisms by which CMECB 
induces apoptosis in Jurkat T cells, we analysed the 
expression levels of Bax and Bcl-2 after CMECB treat-
ment using real time quantitative RT-PCR. The real time 
quantitative RT-PCR data demonstrated that treatment of 
Jurkat T cells with CMECB did not have any effect on the 
expression levels of Bcl-2 mRNA after 24 h of treatment 
(data not shown). However, there was decreased 
expression of Bcl-2 mRNA levels in the presence of 100, 
400 and 600 µg/ml of the extract after 48 and 72 h of 
treatment (Figure 3 shows expression data for treatment 
after 48 h). Bcl-2 mRNA expression was down-regulated 
by factors of 2.5 (p-value = 0.022) and 6.8 (p-value = 
0.034) in samples treated with 100 and 400 µg/ml 
CMECB, respectively, for 48 h in comparison with the 
untreated samples. On the other hand, Bax mRNA 
expression levels showed 3.1 (p-value = 0.046) and 5.2 
(p-value = 0.047) fold increases after treatment with 100 
and 400 µg/ml CMECB, respectively, for 48 h in 
comparison with the untreated samples. 
 
 
CMECB induces apoptosis by regulating the 
expression of Bax, Bcl-2 and p53 proteins 
  
Western blot analysis of Bcl-2 and Bax proteins showed 
that CMECB down-regulated Bcl-2 protein levels in a 
dose-dependent manner (Figure 4A). Increased Bax 
protein levels were observed in cultures treated with 100 
and 250 µg/ml of the extract after 24 and 48 h of 
treatment. We also observed increased Bax protein 
levels in all treated cells after 72 h (Figure 4A). These 
results suggest that the down-regulation of Bcl-2 expres-
sion and a concomitant increased expression of Bax 
might, in part, contribute to the occurrence of the 
apoptotic process in CMECB-treated Jurkat T cells. Den-
sitometric analysis was subsequently used to corroborate 
the observed down-regulation of Bcl-2 and the up-
regulation of Bax (Figure 4B). 
The possible role of p53 in the CMECB-induced apop-
tosis of Jurkat T cells was also investigated. Western blot 
analysis demonstrated a dose- and time- dependent up-
regulation of p53, and phosphorylation at 48 and 72 h 
(Figure 4A). The results suggested that CMECB-induced 
apoptosis of Jurkat T cells could be mediated through a 
p53-dependent pathway. 
 
 
DISCUSSION 
 
The aim of the present study was to evaluate the effect of  
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Figure 3. Effects of CMECB on bax and bcl-2 mRNA expression levels in Jurkat T cells 
after 48 h. Cells were treated with various concentrations of CMECB or vehicle control 
(DMSO) and mRNA expression levels were determined by quantitative real time RT-PCR. 
 
 
 
the crude methanolic extract of C. benghalensis 
(CMECB) in Jurkat T cell proliferation, and to further 
elucidate possible molecular and biochemical mechani-
sms that may occur as a result of challenging Jurkat T 
cells with CMECB. This study has demonstrated that the 
treatment of Jurkat T cells with CMECB resulted in a 
dose- and time-dependent inhibition of cell proliferation 
and a concurrent decrease in cell viability (Figure 1). 
These results suggest that CMECB induced cell death of 
Jurkat T cells. Consequently, morphological changes 
known to be associated with apoptosis were investigated. 
The advent of an apoptotic process is confirmed by the 
presence of defined and systematic morphological 
changes such as rapid reduction in the cellular volume 
(cell shrinkage), chromatin condensation and fragmen-
tation, followed by the formation of apoptotic bodies (Lau 
et al., 2004). Our results indeed demonstrated that Jurkat 
T cells treated with different concentrations of the 
CMECB displayed the aforementioned morphological 
hallmarks of apoptosis (Figure 2).  
The Bcl-2 family of genes consists of the pro-apoptotic 
and anti-apoptotic members such as bax and bcl-2, 
respectively (Miyoshi et al., 2003). Bcl-2 as a key 
regulator of apoptosis, promotes cell survival either by 
inhibiting factors for the activation of caspases (Ling et 
al., 2002) or by regulation of apoptosis through functional 
antagonism through the formation of heterodimers with 
other Bcl-2 family members. Bax, a pro-apoptotic mem-
ber, on the other hand, binds to the anti-apoptotic Bcl-2 
protein and thus acts by antagonising the function of Bcl-
2 to abrogate apoptosis. Induction of Bax is also reported 
to promote cytochrome c release from the mitochondria, 
which eventually leads to apoptosis (Thomas et al., 
2000). In this study, an apparent increase in the 
expression of Bax and a concomitant decrease in Bcl-2 
mRNA expression levels, as determined by real time 
quantitative RT-PCR, were observed in the CMECB-
treated Jurkat T cells (Figure 3). In agreement with the 
real time quantitative RT-PCR analysis, an increase in 
Bax protein expression was observed in CMECB-treated 
Jurkat T cells (Figure 4A). More importantly, the expres-
sion levels of Bcl-2 protein were concurrently down-
regulated after CMECB treatment (Figure 4A); hence the 
ratio of pro-apoptotic proteins to the anti-apoptotic 
proteins was altered in favour of apoptosis (Figure 4B). 
Thus, the results suggest that an up- regulation of Bax 
and the corresponding down-regulation of Bcl-2 proteins 
observed in this study may be one of the critical 
mechanisms through which CMECB induces apoptosis in 
Jurkat T cells. 
Furthermore, our results showed that treatment of 
Jurkat T cells resulted in an increased expression and 
phosphorylation levels of p53 (Figure 4A). p53 protein is 
one of the key regulators of apoptosis and plays a crucial 
role in cell division cycle arrest to allow for the repair of 
damaged cellular DNA. In addition, post-translational 
modifications, such as phosphorylation, play an important 
role in the stabilisation, up-regulation and  functional  acti- 
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Figure 4. Expression of Bax, Bcl-2 and p53 proteins in CMECB-treated Jurkat T cells (A). Cells were treated with 
indicated concentrations of CMECB or vehicle control (DMSO) for 24-72 h and protein expression determined by western 
blotting as described in the materials and methods. The ratio of Bax-to-Bcl-2 expression was determined by densitometric 
analysis (B). 
 
 
 
vity of p53 protein (Sutcliffe and Brehm, 2004). Although 
the mechanism of p53-mediated apoptosis, after cellular 
stress, remains incompletely characterised, substantial 
evidence suggests that p53 may induce apoptosis, at 
least in part, by regulating the transcription of a number 
of target genes involved in the regulation of apoptosis 
(Bax, Bcl-2, Fas/APO1, KILLER/DR5, Tsp1, etc) and cell 
division cycle (p21WAF1/CIP1, GADD45, MDM2, 14-3-3σ, 
etc) (Lee et al., 2003). Therefore, the data seem to 
suggest that CMECB up-regulates the expression of p53, 
with a simultaneous down-regulation of Bcl-2 protein and 
an up-regulation of Bax, thus altering their ratio in favour 
of an apoptotic cell death of Jurkat T cells. 
Conclusion 
 
The study suggests that both the Bcl-2 family of proteins 
(Bax and Bcl-2) and the p53 tumour suppressor protein 
play a pivotal role in CMECB-induced apoptotic cell death 
of Jurkat T cells. These findings might help explain and 
accentuate the purported anticancer properties of 
CMECB and may further provide scientific evidence that 
validates the ethnopharmacological use of C. benghalen-
sis. Further investigations regarding the purification and 
identification of the active compounds, the effect of 
CMECB on the regulation of cell division cycle genes, as 
well as the elucidation of both  the  up- and  down-stream  
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apoptotic regulators and effectors that may facilitate the 
events leading to CMECB-induced apoptosis are 
warranted. 
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